Table 6.
Parameters | miR-19b-3p | miR-92a-3p | miR-122-5p | miR-486-5p | miR-663a | miR-320b | miR-877-5p | miR-1180-3p | |
---|---|---|---|---|---|---|---|---|---|
Age | r | 0.128 | 0.254* | -0.086 | 0.423** | 0.186 | 0.036 | -0.038 | 0.040 |
P_value | 0.204 | 0.011 | 0.397 | <0.001 | 0.304 | 0.721 | 0.706 | 0.692 | |
Gender | r | 0.186 | 0.086 | -0.056 | 0.034 | 0.040 | -0.154 | 0.075 | -0.004 |
P_value | 0.063 | 0.396 | 0.581 | 0.740 | 0.693 | 0.127 | 0.456 | 0.970 | |
Disease duration | r | 0.354** | 0.150 | -0.045 | 0.222* | 0.154 | 0.069 | 0.051 | 0.085 |
P_value | <0.001 | 0.137 | 0.654 | 0.026 | 0.127 | 0.495 | 0.615 | 0.403 | |
VAS pain rest | r | 0.142 | 0.201 | 0.085 | 0.285** | 0.103 | 0.224* | -0.093 | 0.110 |
P_value | 0.159 | 0.076 | 0.403 | 0.004 | 0.309 | 0.025 | 0.357 | 0.274 | |
VAS pain walking | r | 0.258** | 0.195 | -0.236* | 0.336** | 0.352** | 0.078 | 0.026 | 0.044 |
P_value | 0.010 | 0.115 | 0.018 | 0.001 | <0.001 | 0.438 | 0.800 | 0.666 | |
WOMAC pain | r | 0.302** | 0.184 | 0.103 | 0.301** | 0.135 | 0.146 | 0.005 | 0.067 |
P_value | 0.002 | 0.159 | 0.306 | 0.002 | 0.182 | 0.147 | 0.964 | 0.505 | |
WOMAC stiffness | r | 0.239* | -0.032 | 0.080 | 0.116 | 0.185 | 0.079 | 0.261** | 0.115 |
P_value | 0.017 | 0.754 | 0.427 | 0.250 | 0.066 | 0.434 | 0.009 | 0.256 | |
WOMAC function | r | 0.122 | 0.202 | 0.137 | 0.310** | 0.037 | -0.064 | -0.095 | -0.076 |
P_value | 0.226 | 0.104 | 0.174 | 0.002 | 0.717 | 0.525 | 0.349 | 0.454 | |
WOMAC total | r | 0.191 | 0.198 | 0.141 | 0.352** | 0.088 | 0.008 | -0.022 | -0.030 |
P_value | 0.057 | 0.184 | 0.162 | <0.001 | 0.383 | 0.938 | 0.829 | 0.771 |
Data was presented as r and P value. Correlation was determined by Spearman test.
P value <0.05 was considered significant;
P value <0.01 was considered extremely significant.
OA, osteoarthritis; VAS, visual analogue scale; WOMAC, Western Ontarioand McMaster Universities Osteoarthritis Index.